larotrectinib
Generic: LAROTRECTINIB SULFATE·Brand: VITRAKVI, Vitrakvi·Code: LOXO-101
larotrectinib: developed by 2 companies. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| ARRAY BIOPHARMA INC (ARRY) | Phase 2 |
| LOXO ONCOLOGY, INC. (LOXO) | BLA Filed |
Get deeper analysis on larotrectinib
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis